Product logins

Find logins to all Clarivate products below.


: Clinical trials

Here you will find relevant articles and insight into all Clarivate related products and news.

Perceptions of pharmaceutical industry affiliates on the New Active Substance Work-Sharing Initiative of the Access Consortium Perceptions of pharmaceutical industry affiliates on the New Active Substance Work-Sharing Initiative of the Access Consortium
Blog July 8, 2024
Perceptions of pharmaceutical industry affiliates on the New Active Substance Work-Sharing Initiative of the Access Consortium
Clinical research Clinical trials Digital health
The role of artificial intelligence or machine learning in conducting systematic literature reviews now and in future The role of artificial intelligence or machine learning in conducting systematic literature reviews now and in future
Blog June 21, 2024
The role of artificial intelligence or machine learning in conducting systematic literature reviews now and in future
Clinical research Clinical trials corporate
Indication Expansion: Pioneering new uses for existing cancer drugs Indication Expansion: Pioneering new uses for existing cancer drugs
Blog May 31, 2024
Indication Expansion: Pioneering new uses for existing cancer drugs
Clinical research Clinical trials Consulting Resource Center
Beyond overall survival: Time to agree on the value of alternative oncology endpoints? Beyond overall survival: Time to agree on the value of alternative oncology endpoints?
Blog May 21, 2024
Beyond overall survival: Time to agree on the value of alternative oncology endpoints?
Clinical research Clinical trials Early drug development research
Unleashing the power of computational tools in rare disease Unleashing the power of computational tools in rare disease
Blog February 28, 2024
Unleashing the power of computational tools in rare disease
Clinical trials Pharma Portfolio strategy
What sets the Drugs to Watch in 2024 apart What sets the Drugs to Watch in 2024 apart
Blog January 8, 2024
What sets the Drugs to Watch in 2024 apart
Clinical trials Mainland China Oncology
Best practices for AI and ML use across the drug discovery and development lifecycle Best practices for AI and ML use across the drug discovery and development lifecycle
Blog November 23, 2023
Best practices for AI and ML use across the drug discovery and development lifecycle
Clinical research Clinical trials Early drug development research
How clinical outcome assessments can help us understand the patient experience How clinical outcome assessments can help us understand the patient experience
Blog November 13, 2023
How clinical outcome assessments can help us understand the patient experience
Alopecia Clinical research Clinical trials

Clinical trials

Blog January 10, 2023
The Drugs to Watch in 2023
Bringing the patient voice into clinical trials with clinical outcome assessments Bringing the patient voice into clinical trials with clinical outcome assessments
Blog November 10, 2022
Bringing the patient voice into clinical trials with clinical outcome assessments
Seven RNA technology companies to keep an eye on Seven RNA technology companies to keep an eye on
Blog November 8, 2022
Seven RNA technology companies to keep an eye on
Antibody drug conjugates and bispecifics seize the spotlight at ASCO 2022 Antibody drug conjugates and bispecifics seize the spotlight at ASCO 2022
Blog June 23, 2022
Antibody drug conjugates and bispecifics seize the spotlight at ASCO 2022
How a “fail fast” approach can set clinical trials up for success How a “fail fast” approach can set clinical trials up for success
Blog May 26, 2022
How a “fail fast” approach can set clinical trials up for success
Clinical trials and pregnancy: regulators weigh in Clinical trials and pregnancy: regulators weigh in
Blog March 17, 2022
Clinical trials and pregnancy: regulators weigh in
Bioinfogate becomes Clarivate Bioinfogate becomes Clarivate
Blog October 25, 2021
Bioinfogate becomes Clarivate
COVID-19: Fighting a global pandemic with innovation COVID-19: Fighting a global pandemic with innovation
Blog October 14, 2021
COVID-19: Fighting a global pandemic with innovation
Top oncology breakthroughs shared at ESMO 2021 Top oncology breakthroughs shared at ESMO 2021
Blog October 7, 2021
Top oncology breakthroughs shared at ESMO 2021
Paradigm-changing primary Phase III data for malignant melanoma: What to expect from Relatlimab in combination with Opdivo Paradigm-changing primary Phase III data for malignant melanoma: What to expect from Relatlimab in combination with Opdivo
Blog June 23, 2021
Paradigm-changing primary Phase III data for malignant melanoma: What to expect from Relatlimab in combination with Opdivo